Table 1 Baseline characteristics of patients
| Â | Control | BM-MSCs | |
|---|---|---|---|
Low-dose | High-dose | ||
N | 10 | 10 | 10 |
Age (years) | 60.3 (55.1, 61.1) | 65.9 (59.5, 70.6) | 57.8 (55.0, 60.8) |
Males, n (%) | 7 (70) | 4 (40) | 8 (80) |
BMI (kg/m2) | 29.6 (26.2, 30.8) | 27.1 (24.4, 31.2) | 28.5 (25.8, 31.0) |
Time since OA diagnosis (years) | 6 (2, 8) | 9 (4, 12) | 10 (7, 15) |
K-L 2, n (%) | 4 (40) | 1 (10) | 3 (30) |
K-L 3, n (%) | 2 (20) | 2 (20) | 3 (30) |
K-L 4, n (%) | 4 (40) | 7 (70) | 4 (40) |